Equity

Iovance Biotherapeutics, Inc. (IOVA) Stock — Today's Move

▼ -35.45%

$9.56

$-5.25 today

IOVA is down 35.45% today. Volume is 58.69M vs a 30-day average of 15.68M (3.74x).

Day High

$11.58

Day Low

$9.35

Open

$10.63

Prev Close

$14.81

Volume

58.69M

Avg Vol (30d)

15.68M

52-Wk High

$15.37

52-Wk Low

$1.76

Sector

—

Today's Move

-35.45%

Next Earnings

Thu, Nov 5

Iovance Biotherapeutics, Inc. is scheduled to report earnings Thu, Nov 5, 2026. Analysts expect EPS of $-0.09 on revenue of about $117.84M. Stocks often move sharply on earnings day.

52-wk low $1.7652-wk high $15.37

IOVA is 57% of the way from its 52-week low to its high.

Indicators:

Close price · volume bars (dashed line = average volume) · news that day (2M–1Y) — hover or tap the chart. Indicators are for education, not trading advice.

Why is IOVA moving today?

SeekingAlpha· Oct 29, 1:58pm

Iovance Biotherapeutics, Inc. (IOVA) Discusses Positive Lifileucel Data and Precision TIL Strategy in Non-small Cell Lung Cancer Transcript

Iovance Biotherapeutics, Inc. (IOVA) Discusses Positive Lifileucel Data and Precision TIL Strategy in Non-small Cell Lung Cancer October 29, 2026 8:30 AM...

SeekingAlpha· Oct 29, 1:40pm

Iovance Biotherapeutics, Inc. (IOVA) Discusses Positive Lifileucel Data and Precision TIL Strategy in Non-small Cell Lung Cancer - Slideshow

2026-10-29. The following slide deck was published by Iovance Biotherapeutics, Inc.

ChartMill· Oct 29, 1:30pm

Premarket Gainers and Losers on Oct. 29, 2026

Premarket movers on Oct. 29, 2026 include NCPL, PCLA, INLF, NUWE, BURU, INSM, CROX, GKOS, MAX, PRCH, IOVA, XRX, FTNT, SFM, TWI, ALNY and NOW.

Yahoo· Oct 29, 12:57am

Why Did IOVA Stock Jump Over 10% After-Hours Today?

Iovance will share positive Phase 2 results for Lifileucel on Thursday, along with a precision-medicine update.

Yahoo· Oct 28, 11:00pm

Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy

Live Webcast at 8:30 a.m. ET on Thursday, October 29, 2026 PHILADELPHIA, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology…

Related Movers

NOW

▼ -26.95%

ServiceNow, Inc.

ServiceNow's AI Momentum Still Too Small to Inflect Overall Growth, Truist Says

$109.67 -$40.46

Vol: 75.55M (5.0x avg) Technology

ALNY

▼ -25.13%

Alnylam Pharmaceuticals, Inc.

ALNY Stock Hits Fresh 52-Week Low On Medicare Access Worries And Pipeline Delays

$174.00 -$58.40

Vol: 11.80M (6.7x avg) Biotechnology

SFM

▼ -22.58%

Sprouts Farmers Market, Inc.

Sprouts: 3 Key Takeaways for Long-Term Investors

$48.00 -$14.00

Vol: 19.37M (9.5x avg) Retail

FTNT

▼ -20.09%

Fortinet, Inc.

Fortinet's Q3 Results Show Disappointing Slowdown Amid Tight Supply, BofA Says

$139.10 -$34.98

Vol: 17.29M (3.9x avg) Technology

FAQ — IOVA

Why is IOVA moving today?

IOVA is down 35.45% in the current session. Scroll to the news section below to see the most recent headlines and catalysts driving the move.

Is Iovance Biotherapeutics, Inc. a good stock to buy today?

WeeklyTrader.io does not provide financial advice. Always verify catalysts, assess risk, and conduct your own research before making any investment decision.

What is IOVA's average volume?

Average volume for IOVA is approximately 15.68M shares per day based on the trailing 30 sessions.

Where can I see more stocks like IOVA?

Visit the sector filter on the gainers and losers pages to see related movers.